| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | - | 44.997 | 198.070 |
| Total Income - EUR | - | - | - | - | - | - | - | - | 44.997 | 200.669 |
| Total Expenses - EUR | - | - | - | - | - | - | - | - | 11.144 | 46.782 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | - | 33.854 | 153.887 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | - | 33.415 | 147.987 |
| Employees | - | - | - | - | - | - | - | - | 1 | 2 |
Check the financial reports for the company - Gavrymed Anmo S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | - | 0 | 1.380 |
| Current Assets | - | - | - | - | - | - | - | - | 35.881 | 155.087 |
| Inventories | - | - | - | - | - | - | - | - | 417 | 676 |
| Receivables | - | - | - | - | - | - | - | - | 455 | 113.832 |
| Cash | - | - | - | - | - | - | - | - | 35.009 | 40.580 |
| Shareholders Funds | - | - | - | - | - | - | - | - | 33.456 | 148.036 |
| Social Capital | - | - | - | - | - | - | - | - | 40 | 40 |
| Debts | - | - | - | - | - | - | - | - | 2.426 | 8.432 |
| Income in Advance | - | - | - | - | - | - | - | - | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Gavrymed Anmo S.r.l.